Limoneira (NASDAQ:LMNR) Stock Rating Lowered by Zacks Research

Limoneira (NASDAQ:LMNRGet Free Report) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

A number of other equities analysts have also recently issued reports on LMNR. Stephens began coverage on shares of Limoneira in a research report on Friday, September 12th. They set an “equal weight” rating and a $18.00 price objective for the company. Lake Street Capital assumed coverage on shares of Limoneira in a report on Wednesday. They set a “buy” rating and a $19.00 price target for the company. Weiss Ratings reissued a “sell (d)” rating on shares of Limoneira in a report on Monday. Finally, Roth Capital reaffirmed a “buy” rating on shares of Limoneira in a report on Monday, September 15th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Limoneira presently has an average rating of “Hold” and a consensus price target of $18.50.

Read Our Latest Stock Report on LMNR

Limoneira Stock Up 1.2%

Shares of LMNR opened at $12.78 on Wednesday. Limoneira has a one year low of $12.20 and a one year high of $25.20. The firm has a 50 day simple moving average of $13.78 and a two-hundred day simple moving average of $14.79. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.35 and a quick ratio of 1.27. The company has a market cap of $231.57 million, a P/E ratio of -13.74 and a beta of 0.39.

Institutional Investors Weigh In On Limoneira

Institutional investors and hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC increased its position in Limoneira by 5.6% during the 2nd quarter. Geode Capital Management LLC now owns 397,720 shares of the company’s stock valued at $6,226,000 after purchasing an additional 20,913 shares during the period. Gamco Investors INC. ET AL increased its position in shares of Limoneira by 14.1% during the third quarter. Gamco Investors INC. ET AL now owns 253,200 shares of the company’s stock worth $3,760,000 after buying an additional 31,200 shares during the period. Riverwater Partners LLC increased its position in shares of Limoneira by 1.7% during the third quarter. Riverwater Partners LLC now owns 244,006 shares of the company’s stock worth $3,623,000 after buying an additional 4,043 shares during the period. Quinn Opportunity Partners LLC raised its stake in Limoneira by 5.2% during the second quarter. Quinn Opportunity Partners LLC now owns 180,357 shares of the company’s stock worth $2,823,000 after buying an additional 8,987 shares during the last quarter. Finally, Peapod Lane Capital LLC lifted its holdings in Limoneira by 17.2% in the third quarter. Peapod Lane Capital LLC now owns 144,369 shares of the company’s stock valued at $2,144,000 after buying an additional 21,211 shares during the period. Institutional investors and hedge funds own 64.35% of the company’s stock.

About Limoneira

(Get Free Report)

Limoneira Company (NASDAQ: LMNR), founded in 1893 and based in Santa Paula, California, is a diversified agribusiness and real estate enterprise. As one of the oldest citrus producers in the United States, Limoneira has built a reputation for cultivating and marketing high-quality citrus fruits, avocados and specialty crops. The company’s vertically integrated model encompasses farming, packing, processing and marketing activities designed to deliver fresh produce to domestic and international markets.

In its agricultural operations, Limoneira specializes in lemons, oranges and avocados, employing modern irrigation, harvesting and packing technologies to maintain consistent product quality and supply.

Recommended Stories

Analyst Recommendations for Limoneira (NASDAQ:LMNR)

Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.